Shanghai Shyndec Pharmaceutical Co Ltd
SSE:600420
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Shanghai Shyndec Pharmaceutical Co Ltd
SSE:600420
|
CN |
|
H
|
Hancom Lifecare Inc
KRX:372910
|
KR |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
US |
|
Coventry Group Ltd
ASX:CYG
|
AU |
|
S
|
Shanghai Yanpu Metal Products Co Ltd
SSE:605128
|
CN |
|
Mitsui Matsushima Holdings Co Ltd
TSE:1518
|
JP |
|
S
|
Slang Worldwide Inc
CNSX:SLNG
|
CA |
|
Mikuni Corp
TSE:7247
|
JP |
|
JFE Systems Inc
TSE:4832
|
JP |
|
O
|
Obara Group Inc
TSE:6877
|
JP |
|
Voxtur Analytics Corp
XTSX:VXTR
|
CA |
|
E
|
E&M Co Ltd
KOSDAQ:089230
|
KR |
|
Medpace Holdings Inc
NASDAQ:MEDP
|
US |
|
Rich Capital Holdings Ltd
SGX:5G4
|
SG |
|
K
|
Keep Inc
HKEX:3650
|
CN |
|
L
|
Ladun Investment Company SCJSC
SAU:9535
|
SA |
|
E
|
Everest Consolidator Acquisition Corp
NYSE:MNTN
|
US |
Wall Street
Price Targets
Price Targets Summary
Shanghai Shyndec Pharmaceutical Co Ltd
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Shanghai Shyndec Pharmaceutical Co Ltd's stock price target?
Not Available
Shanghai Shyndec Pharmaceutical Co Ltd doesn't have any price targets made by Wall Street professionals.
What is Shanghai Shyndec Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
13%
For the last 13 years the
compound annual growth rate for
Shanghai Shyndec Pharmaceutical Co Ltd's revenue is
15%.
The projected
CAGR
for the next 2 years is
13%.
What is Shanghai Shyndec Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
22%
For the last 13 years the
compound annual growth rate for
Shanghai Shyndec Pharmaceutical Co Ltd's operating income is
20%.
The projected
CAGR
for the next 2 years is
22%.
What is Shanghai Shyndec Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
22%
For the last 13 years the
compound annual growth rate for
Shanghai Shyndec Pharmaceutical Co Ltd's net income is
18%.
The projected
CAGR
for the next 2 years is
22%.
